METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–14. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022; 135(5):584–590. doi:10.1097/CM9.0000000000002108.
   PubMed Web of Science ®Google Scholar
• Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R, Poljak M, Murillo R, Broutet N, Riley LM, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Global Health. 2022; 10(8):e1115–e27. doi:10.1016/S2214-109X(22)00241-8.
   PubMed Web of Science ®Google Scholar
• Rizzuto I, Otter SJ, Bharathan R, Stewart A. Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer. Cochrane Database Syst Rev. 2020. 10.1002/14651858.CD013605.
   Google Scholar
• Wang J, Lv F, Sun T, Zhao S, Chen H, Liu Y, Liu Z. Sorafenib nanomicelles effectively shrink tumors by vaginal administration for preoperative chemotherapy of cervical cancer. Nanomaterials. 2021;11(12):3271. doi:10.3390/nano11123271.
   Web of Science ®Google Scholar
• Lan Q, Liu PY, Haase J, Bell JL, Hüttelmaier S, Liu T. The critical role of RNA m6A methylation in cancer. Cancer Res. 2019;79(7):1285–1292. doi:10.1158/0008-5472.CAN-18-2965.
   PubMed Web of Science ®Google Scholar
• Paramasivam A, Priyadharsini JV. RNA N6-methyladenosine: a new player in autophagy-mediated anti-cancer drug resistance. Br J Cancer. 2021;124(10):1621–1622. doi:10.1038/s41416-021-01314-z.
   PubMed Web of Science ®Google Scholar
• Ma X, Li Y, Wen J, Zhao Y. m6A RNA methylation regulators contribute to malignant development and have a clinical prognostic effect on cervical cancer. Am J Transl Res. 2020;12(12):8137–8146.
   PubMed Web of Science ®Google Scholar
• Zhou H, Yin K, Zhang Y, Tian J, Wang S. The RNA m6A writer METTL14 in cancers: roles, structures, and applications. Biochimica Et Biophysica Acta (BBA) - Rev Cancer. 2021;1876(2):188609. doi:10.1016/j.bbcan.2021.188609.
   PubMed Web of Science ®Google Scholar
• Geng F, Fan M-J, Li J, Liang S-M, C-Y L, Li N. Knockdown of METTL14 inhibits the growth and invasion of cervical cancer. Transl Cancer Res. 2019;8(6):2307. doi:10.21037/tcr.2019.09.48.
   PubMed Web of Science ®Google Scholar
• Hu C, Liu T, Xu Y, Han C, Yang S, Yang K. METTL14 promotes the proliferation and migration of cervical cancer cells by up-regulating m(6)A myc expression. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2022;38(2):131–137.
   PubMedGoogle Scholar
• Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266–282. doi:10.1038/s41580-020-00324-8.
   PubMed Web of Science ®Google Scholar
• Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107–125. doi:10.1038/s41422-020-00441-1.
   PubMed Web of Science ®Google Scholar
• Shen Z, Song J, Yung BC, Zhou Z, Wu A, Chen X. Emerging strategies of cancer therapy based on ferroptosis. Adv Mater. 2018;30(12):1704007. doi:10.1002/adma.201704007.
   PubMed Web of Science ®Google Scholar
• Yang X, Yin F, Liu Q, Ma Y, Zhang H, Guo P, Wen W, Guo X, Wu Y, Yang Z, et al. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer. Ann Transl Med. 2022; 10(2):123. doi:10.21037/atm-21-6265.
   PubMed Web of Science ®Google Scholar
• Wang C, Zeng J, L-J L, Xue M, S-L H. Cdc25A inhibits autophagy-mediated ferroptosis by upregulating ErbB2 through PKM2 dephosphorylation in cervical cancer cells. Cell Death Disease. 2021;12(11):1055. doi:10.1038/s41419-021-04342-y.
   PubMed Web of Science ®Google Scholar
• Fan Z, Yang G, Zhang W, Liu Q, Liu G, Liu P, Xu L, Wang J, Yan Z, Han H, et al. Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11. J Cell Mol Med. 2021; 25(21):10197–10212. doi:10.1111/jcmm.16957.
   PubMed Web of Science ®Google Scholar
• Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, Wang Q, Wang S, Rong D, Reiter FP, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020; 5(1):87. doi:10.1038/s41392-020-0187-x.
   PubMed Web of Science ®Google Scholar
• Li Q, Chen K, Zhang T, Jiang D, Chen L, Jiang J, Zhang C, Li S. 2023. Understanding sorafenib-induced ferroptosis and resistance mechanisms: implications for cancer therapy. Eur J Pharmacol. 955:175913. doi:10.1016/j.ejphar.2023.175913.
   PubMed Web of Science ®Google Scholar
• Ratnadiwakara M, Anko ML. mRNA stability assay using transcription inhibition by actinomycin D in mouse pluripotent stem cells. Bio Protoc. 2018;8(21):e3072. doi:10.21769/BioProtoc.3072.
   PubMedGoogle Scholar
• Wenbin H, Kunling C, Yishi L, Donghui Z, Yuan C, Liuran L, Huang W, He G, Liao H, Cai L, et al. ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma. Neoplasia. 2021; 23(12):1227–1239. doi:10.1016/j.neo.2021.11.002.
   PubMed Web of Science ®Google Scholar
• Jia L, Ji Ling J, Yi Mei C, Wei Qi LJJPCR. KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway. J Pathol: Clin Res. 2023;9(5):423–435. doi:10.1002/cjp2.325.
   PubMedGoogle Scholar
• Hua S, Chao P, Yang LJFCDB. Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer. 2024; 12.
   Google Scholar
• Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169–182. doi:10.1016/S0140-6736(18)32470-X.
   PubMed Web of Science ®Google Scholar
• Deng L-J, Deng W-Q, Fan S-R, Chen M-F, Qi M, Lyu W-Y, Qi Q, Tiwari AK, Chen J-X, Zhang D-M, et al. m6A modification: recent advances, anticancer targeted drug discovery and beyond. Mol Cancer. 2022; 21(1):52. doi:10.1186/s12943-022-01510-2.
   PubMed Web of Science ®Google Scholar
• Xie Q, Li Z, Luo X, Wang D, Zhou Y, Zhao J, Gao S, Yang Y, Fu W, Kong L, et al. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner. J Transl Med. 2022; 20(1):51. doi:10.1186/s12967-022-03257-2.
   PubMed Web of Science ®Google Scholar
• Tang D, Cao F, Yan C, Cui J, Guo X, Cheng L, Li L, Li Y-L, Ma J-M, Fang K, et al. Acinar cell-derived extracellular vesicle MiRNA-183-5p aggravates acute pancreatitis by promoting M1 macrophage polarization through downregulation of FoxO1. Front Immunol. 2022;13:869207. doi:10.3389/fimmu.2022.869207.
   PubMed Web of Science ®Google Scholar
• Plays M, Müller S, Rodriguez R. Chemistry and biology of ferritin. Metallomics. 2021;13(5). doi:10.1093/mtomcs/mfab021.
   PubMed Web of Science ®Google Scholar
• Di Sanzo M, Quaresima B, Biamonte F, Palmieri C, Faniello MC. FTH1 pseudogenes in cancer and cell metabolism. Cells. 2020;9(12):2554. doi:10.3390/cells9122554.
   PubMed Web of Science ®Google Scholar
• Zhu M, Shen W, Wang Q, Zhou X, Wang J, Wang T, Zhang J. DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m6A modification and translation for cytoprotective autophagy in cervical cancer. RNA Biol. 2022;19(1):751–763. doi:10.1080/15476286.2022.2079889.
   PubMed Web of Science ®Google Scholar
• Kong N, Chen X, Feng J, Duan T, Liu S, Sun X, Chen P, Pan T, Yan L, Jin T, et al. Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1. Acta Pharm Sin B. 2021; 11(12):4045–4054. doi:10.1016/j.apsb.2021.03.036.
   PubMed Web of Science ®Google Scholar
• Tian Y, Lu J, Hao X, Li H, Zhang G, Liu X, et al. FTH1 inhibits ferroptosis through ferritinophagy in the 6-OHDA model of Parkinson’s disease. Neurotherapeutics. 2020;17:1796–1812. doi:10.1007/s13311-020-00929-z.
   PubMed Web of Science ®Google Scholar
• Zhang R, Pan T, Xiang Y, Zhang M, Xie H, Liang Z, Chen B, Xu C, Wang J, Huang X, et al. Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19/miR-19b-3p/FTH1 axis. Bioact Mater. 2022;13:23–36. doi:10.1016/j.bioactmat.2021.11.013.
   PubMed Web of Science ®Google Scholar
• Hu Z-W, Wen Y-H, Ma R-Q, Chen L, Zeng X-L, Wen W-P, Sun W. Ferroptosis driver SOCS1 and suppressor FTH1 independently correlate with M1 and M2 macrophage infiltration in head and neck squamous cell carcinoma. Front Cell Dev Biol. 2021;9. doi:10.3389/fcell.2021.727762.
   Web of Science ®Google Scholar